1. Home
  2. PAL vs TRVI Comparison

PAL vs TRVI Comparison

Compare PAL & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAL
  • TRVI
  • Stock Information
  • Founded
  • PAL 2023
  • TRVI 2011
  • Country
  • PAL United States
  • TRVI United States
  • Employees
  • PAL N/A
  • TRVI N/A
  • Industry
  • PAL
  • TRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAL
  • TRVI Health Care
  • Exchange
  • PAL NYSE
  • TRVI Nasdaq
  • Market Cap
  • PAL 248.9M
  • TRVI 211.4M
  • IPO Year
  • PAL 2024
  • TRVI 2019
  • Fundamental
  • Price
  • PAL $8.87
  • TRVI $4.48
  • Analyst Decision
  • PAL Strong Buy
  • TRVI Strong Buy
  • Analyst Count
  • PAL 4
  • TRVI 8
  • Target Price
  • PAL $17.33
  • TRVI $9.31
  • AVG Volume (30 Days)
  • PAL 154.8K
  • TRVI 4.0M
  • Earning Date
  • PAL 11-08-2024
  • TRVI 11-06-2024
  • Dividend Yield
  • PAL N/A
  • TRVI N/A
  • EPS Growth
  • PAL N/A
  • TRVI N/A
  • EPS
  • PAL N/A
  • TRVI N/A
  • Revenue
  • PAL $147,414,098.00
  • TRVI N/A
  • Revenue This Year
  • PAL N/A
  • TRVI N/A
  • Revenue Next Year
  • PAL $10.77
  • TRVI N/A
  • P/E Ratio
  • PAL N/A
  • TRVI N/A
  • Revenue Growth
  • PAL N/A
  • TRVI N/A
  • 52 Week Low
  • PAL $8.06
  • TRVI $1.26
  • 52 Week High
  • PAL $21.01
  • TRVI $4.60
  • Technical
  • Relative Strength Index (RSI)
  • PAL N/A
  • TRVI 75.02
  • Support Level
  • PAL N/A
  • TRVI $2.36
  • Resistance Level
  • PAL N/A
  • TRVI $4.60
  • Average True Range (ATR)
  • PAL 0.00
  • TRVI 0.33
  • MACD
  • PAL 0.00
  • TRVI 0.21
  • Stochastic Oscillator
  • PAL 0.00
  • TRVI 92.46

About PAL PROFICIENT AUTO LOGISTICS INC

Proficient Auto Logistics Inc is a non-union, specialized freight company focused on providing auto transportation and logistics services. The company operates auto transportation fleets in North America based upon information obtained from the Auto Haulers Association of America, utilizing auto transport vehicles and trailers daily, including Company-owned transport vehicles and trailers. The reportable segments of the company are Truckload and Brokerage. The company derives maximum revenue from the brokerage segment that retains the customer relationship, including billing and collection, and outsources the transportation of the loads to third-party carriers.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: